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Background. The apical potassium (K1) channels mediate K1
recycling in thick ascending limb (TAL) and K1 secretion in
cortical collecting duct (CCD). Recently, the cDNAs for a family
of renal K1 channels, ROMK1, -2 and -3, were identified. Based
on the biophysical properties and mRNA distribution, it is
believed that these ROMK cDNAs encode the apical K1 channels
of TAL and CCD. However, the information for cellular and
subcellular localization of the ROMK proteins in these tubules is
still not available.
Methods. Paraffin or frozen kidney sections from adult Sprague-
Dawley rats were stained by polyclonal antibodies against the N-
and C-terminal domain of ROMK. Immunoreactive staining was
visualized by color development from horseradish peroxidase
reaction. Membrane homogenates from kidney were analyzed by
Western blot analysis.
Results. The polyclonal antibodies against cytoplasmic epitope
of ROMK recognized a ;42 kD protein in the membrane
homogenates from kidney, but not from liver. Staining by immu-
nocytochemistry revealed that ROMK channels were localized to
the apical membranes of the distal nephron in cortex and outer
medulla, including thick ascending limb and collecting tubule.
ROMK staining was absent in glomerulus, proximal tubule and
inner medulla. Double staining of the tissue section with both
ROMK-specific and H1-ATPase-specific antibodies revealed la-
beling of ROMK in the principal cells of the collecting tubules.
Conclusions. These results further strengthen the idea that
ROMK channels play important roles in the recycling of K1 in
TAL and the secretion of K1 in CCD.
Potassium channels play important roles in the regula-
tion of water and electrolyte transport in the kidney. In the
thick ascending limb of Henle’s loop, the recycling of K1
ion across apical K1 channels is essential for NaCl reab-
sorption through the apical Na1/K1/2Cl2 cotransporter. In
the collecting tubules, secretion of K1 is mediated by an
active transport of K1 into the cell through the basolateral
Na1/K1 ATPase and followed by a passive movement of
K1 into the tubular fluid through apical K1 channels [1].
The apical K1 channels in the thick ascending limb (TAL)
[2] and cortical collecting duct (CCD) [3–5] are called
low-conductance secretory K1 (SK) channels. These chan-
nels are highly selective for K1 with the single-channel
conductance of ;30 to 40 pS, are slightly inward-rectifying
on current-voltage (I-V) relationship, and have high open
probability (Po) in the resting membrane potential. Addi-
tional features of these channels include their sensitivity to
inhibition by intracellular ATP, acidity and sulfonylureas,
and the resistance to tetraethylammonium (TEA) [6].
Recently, cDNA for a renal K1 channel, rat outer
medulla K1 channel (ROMK1) [7] and its splice isoforms,
ROMK2 and -3 have been identified [8, 9]. The cDNA for
ROMK1 encodes a 391 amino acids polypeptide. ROMK2
encodes a 372 amino acids polypeptide that lacks the first
19 amino acids of ROMK1, but is otherwise identical to
ROMK1. ROMK3 encodes a 399 amino acid polypeptide
that has an unique sequence for the first 19 amino acids in
the N-terminus. The remaining amino acids 20 to 399 for
ROMK3 are identical to amino acids 13 to 391 for
ROMK1. The three ROMK polypeptides belong to a large
family of inward-rectifying K1 channels with two trans-
membrane spanning domains, one pore-forming region and
cytoplasmic N-terminal and C-terminal domains [10]. In-
ward-rectifying K1 channels are either homomultimers of
the same channel polypeptide or heteromultimers of two
different polypeptides [11, 12].
The similarity in the biophysical and regulatory proper-
ties suggests that ROMK isoforms encode the apical secre-
tory K1 channels [13]. The distribution of transcripts for
the three ROMK isoforms along the nephron further
supports that ROMKs represent the secretory K1 channel
observed in TAL and the principal cells of collecting ducts
[8, 14]. Using reverse transcription-polymerase chain reac-
tion (RT-PCR) to detect mRNA expression from individ-
ual isolated tubular segments, Boim et al reported the
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expression of ROMK1 in CCD and outer medullary col-
lecting duct (OMCD), ROMK2 in TAL, distal convoluted
tubule (DCT), connecting tubule (CNT) and CCD, and
ROMK3 in TAL, DCT and CNT [8]. Thus, the apical K1
channels in principal cells of CCD may be homomultimers
of ROMK2, homomultimers of ROMK1 and/or heteromul-
timers of ROMK2 and ROMK1. Likewise, the apical K1
channels in thick ascending limb may be homomultimers of
ROMK2, homomultimers of ROMK3 and/or heteromul-
timers of ROMK2 and ROMK3. However, the information
for localization of ROMK to apical membranes in these
cells is not available.
To study the cellular and subcellular localization of
ROMK channels in these nephron segments, we character-
ized two polyclonal antibodies against the cytoplasmic
domains of ROMK1 and examined the distribution of the
ROMK proteins in rat kidney using immunoblot analysis
and immunocytochemistry.
METHODS
Expression of recombinant ROMK proteins in Sf 9 cells
Recombinant hexahistidine (H6)-tagged ROMK2 pro-
tein was expressed in Sf 9 cells using a modified pVL-H6
baculovirus transfer vector previously described by us [15].
Briefly, nucleotide containing coding region of the cDNA
for ROMK2 was amplified by polymerase chain reaction
(PCR) using a forward primer containing a BamHI site 59
to the initiation codon and a reverse primer containing an
EcoRI site 39 to the stop codon and subcloned into BamHI
and EcoRI sites of the pVL-H6 vector (pVL-H6-ROMK2).
Recombinant baculovirus containing cDNA for ROMK2
was obtained by co-transfecting pVL-H6-ROMK2 with a
linearlized baculovirus AcMNPV DNA (Invitrogen).
ROMK2 protein was obtained by infecting Sf 9 cells with
recombinant virus at a multiplicity of infection of 5 and
harvested at 48 hours. Cells were homogenized and mem-
brane fractions containing ROMK2 proteins were obtained
by differential centrifugation.
Expression and purification of glutathione S-transferase
fusion protein of ROMK1
Glutathione-S-transferase (GST) fusion proteins con-
taining the C-terminal domain of ROMK1 (GST-RKC) or
IRK1 (GST-IKC) was expressed using a pGEX-2T vector
(Pharmacia) and purified as previously described by us [15].
Briefly, nucleotides corresponding to the putative C-termi-
nal cytoplasmic domain of ROMK1 (amino acids 180 to
391) or IRK1 (amino acids 182 to 428) [16] was amplified
by PCR using a forward primer containing a BamHI site,
and a reverse primer containing an EcoRI site and sub-
cloned into BamHI and EcoRI sites of pGEX-2T vector.
Fusion proteins was induced in DE 3 cells by 0.4 mM IPTG
at 37°C for one to four hours. Bacterial lysates containing
GST-RKC or GST-IKC was purified using glutathione 4B
sepharose beads and eluted with 50 mM of reduced gluta-
thione. The concentration of purified proteins was quanti-
fied by Bradford protein assay (Bio-Rad).
Animal and tissue preparation
Adult Sprague-Dawley rats (Sasco, Omaha, NB, USA)
were anesthetized by intramuscular injection of ketamine
and killed. For immunoblot analysis, kidney and liver were
dissected immediately after sacrifice as previously de-
scribed [17]. Tissue were homogenized using a Teflon-glass
homogenizer in an isolation buffer containing 250 mM
sucrose, 30 mM HEPES pH 7.5, 5 mM EDTA, 100 mg/ml
PMSF, 2 mg/ml leupeptin and 2 mg/ml aprotinin at 4°C.
Membrane fractions were pelleted by centrifugation at
120,000 3 g for 30 minutes (Beckman L8-70M ultracentri-
fuge, 70Ti rotor at 40,000 rpm, 4°C).
Antibody production and immunoblot analysis
Synthetic peptides (KLH conjugated) corresponding to
amino acids 10 to 37 of the N-terminal domain or amino
acids 360 to 391 of the C-terminal domain of ROMK1 were
used to raise polyclonal antibodies in rabbits. The antisera
were affinity-purified using a commercial kit (ImmunoPure
Ag/Ab immobilization kit #2; Pierce Chemical Co. Rock-
ford, IL, USA). Peptides with terminal cysteine were
immobilized to the SulfoLink gel (6% cross-linked agarose)
through the sulfhydryl residue. Antisera were passed
through the immobilized column. Antibodies bound to the
column were eluted off using 100 mM glycine buffer (pH 2.5
to 3) and neutralized by 1 M Tris (pH 9.5). Affinity-purified
antibodies were quantified by OD280, dialyzed in PBS and
stored in 220°C.
For immunoblot analysis, proteins were separated by 7.5
to 10% SDS-PAGE and transferred to nitrocellulose mem-
brane. Nitrocellulose membranes were incubated with af-
finity-purified polyclonal antibodies against the C-terminus
(ROMK-C antibodies) or the N-terminus (ROMK-N anti-
bodies) of ROMK1 at room temperature for two hours and
with horseradish peroxidase-coupled donkey anti-rabbit
secondary antibodies (1:5000 dilution) and visualized using
enhanced chemiluminescence (ECL; Amersham).
Immunohistochemistry
Kidneys from Sprague-Dawley rats were removed and
sliced in coronal sections. Tissue were fixed in 10% form-
aldehyde solution overnight and embedded in paraffin.
Serial paraffin sections were cut into 2 m thickness and
immunostained using procedures described previously [18].
Tissue specimens were incubated with ROMK-C antibod-
ies, ROMK-N antibodies, anti-Tamm Horsfall protein
(THP) antisera (goat anti-human THP; ICN Pharmaceuti-
cals, Inc.) or anti-H1-ATPase antisera (anti-70 kD, subunit
A antisera, #665) [19] in PBS containing 1% BSA at the
dilutions of 1:250, 1:100, 1:1000 or 1:5000, respectively.
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Specimens were further incubated with horseradish perox-
idase (HRP)-coupled donkey anti-rabbit or anti-goat anti-
bodies (1:200 to 1:500 dilution) and visualized using a
blue-color developing peroxidase substrate TrueBlue
(Kirkegaard & Perry Laboratories Inc., Gaithersburg, MD,
USA). Endogenous peroxidase activity was eliminated by
pre-incubating specimens with a blocking solution contain-
ing 0.3% periodic acid (Kirkegaard & Perry Lab.). As the
control, tissue specimens were incubated with pre-immune
rabbit sera and processed as above. The slides were
counter-stained with ContrastRed (Kirkegaard & Perry
Lab.).
For double labeling of Tamm-Horsfall and ROMK pro-
teins, specimens were first incubated with ROMK-C anti-
bodies and processed for peroxidase reaction using a
brown-color developing substrate 3,39-diaminobenzidine
(DAB). After acid treatment using 200 mM glycine buffer
(pH 2.2) to dissociate the initial antigen-antibody com-
plexes, specimens were next incubated with
anti-H1-ATPase antisera and processed using a blue-color
developing substrate TrueBlue (Kirkegaard & Perry Lab.).
For frozen sections, tissue were submersed in liquid
nitrogen immediately after removal. Frozen sections were
cut into 2 to 4 m thickness and fixed in 4% ice-cold
paraformaldehyde for 10 minutes. After washing with PBS,
sections were stained with antibodies using a procedure as
previously described [18].
RESULTS
Characterization of ROMK-specific antibodies
Polyclonal antibodies against synthetic peptides corre-
sponding to amino acids 360 to 391 of the C-terminal
domain of ROMK1 (ROMK-C antibodies) were raised in
rabbits. The sensitivity and specificity of the ROMK-C
antibodies to ROMK protein was examined using trun-
cated recombinant bacterial fusion proteins and recombi-
nant ROMK proteins expressed in Sf 9 cells. As shown in
Figure 1A, the affinity-purified ROMK-C antibodies (0.5
mg/ml) detected as low as 1 ng of GST fusion protein of the
C-terminal domain of ROMK1 (GST-RKC), but not 1 mg
of GST fusion protein of the C-terminal domain of a
distantly related inward-rectifying K1 channel, IRK1
(GST-IKC). Similarly, ROMK-C antibodies immunopre-
cipitated recombinant GST-RKC but not GST-IKC (not
shown). The specificity for the ROMK-C antibodies was
further demonstrated by the ability of these antibodies to
recognize a protein with the predicted molecular size for
the full-length ROMK2 in Sf 9 cells infected with recom-
binant virus containing cDNA for ROMK2, but not in the
control untransfected cells (Fig. 1B). As the antigenic
epitope for the ROMK-C antibodies is conserved in all
three isoforms, the antibody could recognize the recombi-
nant ROMK2 protein. The higher and lower molecular
weight bands were probably glycosylated form [7] and
proteolytic fragment of ROMK2, respectively. These re-
sults demonstrate that ROMK-C antibodies are specific for
the ROMK channel proteins.
Another antibody, ROMK-N (which was raised against
the synthetic peptides corresponding to amino acids 10 to
37 of the N-terminus of ROMK1), was only weakly reactive
with the GST fusion protein of the N-terminus of ROMK1
(requiring at least 20 ng of purified GST-RKN for detec-
tion) and was not useful for immunoblot analysis of ROMK
in kidney (data not shown). ROMK-N antibody, however,
was sufficiently reactive for immunohistochemistry (see
below), suggesting that ROMK-N antibodies recognize the
folded protein (as in immunohistochemistry) better than
the denatured protein (as in immunoblot analysis).
Immunoblot analysis for ROMK immunoreactivity in the
kidney
To examine the native channels, kidney and liver tissue
were homogenized and membrane fractions were obtained
by differential centrifugation. When the nitrocellulose filter
containing these membrane homogenates was probed with
the ROMK-C antibodies (1.5 mg/ml) in the immunoblot
analysis, a protein band in the neighborhood of the pre-
dicted molecular weight for ROMK (; 42 kD) was labeled
in kidney but not in liver (Fig. 2, left panel; indicated by
arrow). Preabsorption the antibodies with the antigenic
peptides prevented the labeling of this band (right panel).
The distribution of the ;42 kD band in kidney but not liver
is consistent with the previous report of mRNA for ROMK
in kidney but not liver [7], suggesting that this band
represents ROMK proteins.
Two higher molecular weight bands, one in ;44 kD the
other in ;77 kD, were seen in both kidney and liver. As
labeling of these higher molecular weight bands were also
prevented by preincubation of antibodies with the antigenic
peptides, these bands may be proteins containing amino
acids homologous to the antigenic epitopes of ROMK and
thus cross-react with the high concentration of the
ROMK-C antibodies necessary for the detection of the low
abundant ROMK proteins in native tissue. Alternatively,
these bands may be complexes of another isoform of
ROMK (which is also present in liver) with or without
associated proteins.
Localization of ROMK by immunohistochemistry
Figure 3A shows the distribution of ROMK channels
stained by ROMK-C antibodies in cortex and outer me-
dulla. There was no staining in inner medulla; the staining
by ROMK-C antibodies disappeared abruptly in the inner
stripe-inner medulla junction. Figure 4 shows the specificity
of ROMK-C antibodies for immunohistochemical staining
in kidney. As shown, similar staining was not observed in
kidney using the control unimmunized serum (Fig. 4, A vs.
B), and nor was it observed in liver using ROMK-C
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antibody (Fig. 4C). Preabsorption of antibodies with anti-
genic peptides prevented the labeling (Fig. 4, D and E vs. F
and G).
Figure 3B is a higher power view of a cortical region
showing labeling of ROMK proteins by ROMK-C antibody
in distal nephron (including CCD, arrowhead), but not in
proximal tubule or glomerulus. The same pattern of label-
ing was observed using another antibodies, ROMK-N,
which were raised against the N-terminal domain of
ROMK1 (Fig. 3C), further supporting the idea that the
labeling is indeed the ROMK proteins. Figure 3 D and E
are higher power views of cortex from specimens stained by
ROMK-N antibodies showing the labeling of ROMK im-
munoreactivity to the apical membranes of the distal
nephron.
To further identify which tubule and cell type contains
ROMK immunoreactivity, we performed double-labeling
using ROMK-C antibodies and anti-THP antisera (which
labels thick ascending limb). Co-localization of the brown
staining (ROMK-C antibody) with the blue staining (anti-
THP antisera) indicates that that ROMK proteins were
present in cTAL (Fig. 3F, labeled “TAL”) and mTAL (Fig.
3G, indicated by arrowheads). ROMK immunoreactivity
was also seen in CCD (Fig. 3F) and OMCD (Fig. 3G). The
localization of ROMK protein to the apical membrane of
principal cells of CCD was further demonstrated by se-
quential staining of consecutive sections using anti-H1-
ATPase antisera (Fig. 3H) and ROMK-N antibodies (Fig.
3I). Figure 3 H and I show partial views of a cortical
collecting duct in two consecutive specimens that were
stained with H1-ATPase antisera and ROMK-N antibod-
ies, respectively. The a-intercalated cell (indicated by ar-
row) was stained by the H1-ATPase antisera (Fig. 3H), but
not by the ROMK-N antibodies (Fig. 3I). Conversely,
principal cells (indicated by arrowheads) were stained by
ROMK-N antibodies, but not by anti-H1-ATPase antisera.
Figures 5 A and B are two consecutive cortical sections
stained by ROMK-C antibodies and anti-THP antisera,
respectively, to further illustrate the localization of ROMK
in CCD (indicated by arrowheads) and cTAL (indicated by
Fig. 1. Characterization of ROMK-C antibodies by immunoblot analysis. (A) Purified fusion proteins of GST-RKC (1, 3, and 10 ng) or GST-IKC (1
mg); (B) membrane homogenates (10 mg each) from Sf 9 cells infected with recombinant baculovirus containing cDNA for ROMK2 or the control
uninfected cells were separated by 10% SDS-PAGE, transferred to nitrocellulose filters and probed with affinity-purified ROMK-C antibodies (0.5
mg/ml) at room temperature for two hours. Immunoreactivity for ROMK as indicated in each panel was visualized using peroxidase-coupled anti-rabbit
secondary antibodies and ECL.
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filled circles). As expected, cTAL (but not CCD) was
stained by anti-THP antisera. Figure 5 C and D are higher
power views of cortex showing staining of cTAL (Fig. 5C,
arrow) and principal cells of CCD.
DISCUSSION
In the present study, we characterized two antibodies
against the N-terminal or the C-terminal cytoplasmic do-
main of ROMK and showed that in Western blot analysis
the C-terminal antibody labeled a ;42 kD band consistent
with the ROMK protein in rat kidney.
During revision of the manuscript, two other groups
published studies using ROMK antibodies. In one study,
Xu et al showed their antibodies detected a 45 kD band as
ROMK and other bands of 85 to 90 kD of a presumed
ROMK dimer, which is not present in inner medulla [20].
In another study, Mennitt et al reported that ROMK
antibodies labeled a stronger band of higher molecular
weight (;75 kD) and a weaker band of lower molecular
weight (;40 kD) in kidney [21]. The pattern of Western
blot analysis in kidney in this latter study is similar to ours
and is particularly interesting because the antigenic pep-
tides used to raise antibodies in the two studies are similar
(amino acids 360 to 391 of ROMK1 in ours vs. amino acids
370 to 391 in theirs). However, the two reports differ in the
interpretation of which band represents ROMK protein.
We found that, while the lower band was present only in
kidney, the higher band was present in both kidney and
liver. As the mRNA for ROMK is absent in liver, we
conclude that the lower molecular weight band is ROMK.
In contrast, Mennitt et al found that neither band was
present in liver and concluded that the higher molecular
weight band at ;75 kD was ROMK. The reason for the
difference for these studies in not clear. One of the
difficulties in Western blot analysis of ROMK in native
tissue may be due to a low abundance and labile nature of
the ROMK protein. Nevertheless, in all three studies, when
recombinant ROMK proteins (from oocytes, cultured HEK
293 cells, Sf 9 cells or in vitro translation) are used for
immunoblotting, only 40 to 45 kD proteins are detected by
ROMK antibodies. Taken together, these evidence indicate
that the ; 40 to 45 kD proteins are ROMKs and that the
Fig. 2. Immunoreactivity of ROMK in rat
kidney. Membrane homogenates (10 mg each)
from whole kidney and liver were separated by
7.5% SDS-PAGE gel, transferred to
nitrocellulose filter and probed with ROMK-C
antibodies (1.5 mg/ml). The lowest two
molecular weight markers (17 and 27 kD) were
run off the gel. The protein band likely
corresponds to ROMK is indicated by arrow.
This band was not observed in membrane
homogenate from liver. In the right panel, the
same nitrocellulose filter was striped and
reprobed with ROMK-C antibody that was
preabsorbed with antigenic peptides (10 mg/ml).
™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™™3
Fig. 3. (A and B) Paraformaldehyde-fixed frozen section specimens stained with ROMK-C antibodies. (C, D and E) Paraffin-embedded specimens
stained with ROMK-N antibodies. (F and G) Paraformaldehyde-fixed frozen section specimens double-stained with anti-THP antisera and ROMK-C
antibodies. (H and I) Paraffin-embedded consecutive specimens stained with H1-ATPase or ROMK-N antibodies, respectively. In panel B, arrowhead
indicates CCD. Abbreviations are: MD, macula densa; Gl, glomerulus; TAL, cortical thick ascending limb; CCD, cortical collecting duct. In panel G
the arrowheads indicate the medullary thick ascending limb. In panels H and I, the arrow indicates an intercalated cell and arrowheads indicate the
principal cells.
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identity of the higher molecular weight band seen in kidney
tissue remains to be defined. This uncertainty about the
higher molecular weight protein in Western blot analysis,
however, does not necessarily invalidate the immunohisto-
chemical study using these antibodies. As the conformation
of the antigen differs in Western blot analysis (denatured
Fig. 4. Specificity of ROMK-C antibodies for immunohistochemical staining. Paraformaldehyde-fixed frozen sections (2 m thickness) of kidney (A, B,
D, E, F and G) or liver (C) were stained by either preimmune rabbit serum (B), ROMK-C antibody (A, C, D and E) or ROMK-C antibody preabsorbed
with antigenic peptides (F and G). Abbreviations are: Gl, glomerulus; Co, cortex; OS, outer stripe, IS, inner stripe of the outer medulla; IM, inner
medulla.
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by SDS) and immunohistochemistry (folding preserved by
fixation), the sensitivity and specificity of antibody for the
two assays can be different.
With respect to the distribution of ROMK in kidney,
previous studies by single tubule in situ hybridization [14] or
single tubule RT-PCR [8] have shown mRNA for ROMK
was present in distal nephron from TAL to OMCD. At the
level of protein distribution, we now show that ROMK
channels are localized to the apical membrane of distal
nephron segments including TAL and CCD, consistent
with the immunohistochemical findings by Xu et al and by
Mennitt et al mentioned as above. Our present study,
however, uses two antibodies against different epitopes
of ROMK and thus provides further evidence that the
immunohistochemical staining by antibody truly represents
the ROMK channel, not a cross-reacting protein sharing
similar antigenic epitope with ROMK.
Because of the similarity in the biophysical and regula-
tory properties, ROMK channels likely represent the low-
conductance secretory K1 (SK) channels in the apical
membrane of thick ascending limb and principal cells of
CCD, which are responsible for K1 recycling and K1
secretion in these nephron segments, respectively. Besides
TAL and CCD, distal tubules including DCT, CNT and
initial collecting duct (ICD) as well as OMCD are also
capable of secreting K1 [22]. The role and the molecular
identity of apical K1 channels for K1 secretion in these
segments, however, are not entirely known. Our present
finding of localization of ROMK channels to the apical
membrane of TAL and principal cells of CCD strengthens
the idea that the cDNAs for ROMK encode at least part of
SK channel proteins. The existence of ROMK immunore-
activity in other distal tubules suggests potential roles for
ROMK channels to mediate K1 secretion in these seg-
ments.
As mentioned in the introductory paragraphs, the three
ROMK isoforms are distributed differently along the
nephron. ROMK1 transcript is found in CCD and OMCD,
ROMK2 is in TAL, DCT, CNT and CCD, ROMK3 is in
TAL, DCT and CNT. Our antibodies raised against the
Fig. 5. Paraformaldehyde-fixed frozen sections (2 m thickness) of kidney were stained by ROMK-C antibody (A, C and D) or anti-THP anti-sera (B).
Panels A and B are consecutive sections. Gl indicates glomerulus. Arrowheads indicate CCD, filled circles indicate cTAL, and arrow in panel C indicates
cTAL.
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common domain cannot distinguish among these isoforms.
The molecular identity and the composition of renal K1
channels, however, is certainly more complex. Other in-
ward-rectifying K1 channels such as RACTK [23], ubiqui-
tous KATP (Kir 6.1) [24], IRK2 [25], IRK3 [26], brain
inward-rectifier BIR10 [27, 28] are also expressed in kid-
ney. The absence of hyperkalemia in patients with Bartter’s
syndrome who have loss-of-function mutations in ROMK
[29] suggests that channels other than ROMK are also
involved in K1 secretion.
Recently, it has also been found that ATP-sensitive K1
channels in pancreas and heart contain another protein,
sulfonylurea binding protein (SUR), in addition to the
pore-forming polypeptides encoded by the inward-rectify-
ing K1 channel cDNAs [30–32]. SUR belongs to the
superfamily of the ATP-binding cassette (ABC) proteins
[33]. Co-expression of another member of ABC proteins,
cystic fibrosis transmembrane regulator (CFTR) with
ROMK2 confers an increased sensitivity of ROMK2 to
sulfonylurea [34]. Inward-rectifying K1 channels are made
up of either homomultimers of the identical pore-forming
polypeptide subunits or heteromultimers of different sub-
units [11, 12]. Whether SK channels are homomultimers
consisting of only ROMK isoforms or are heteromultimers
of the mixture of ROMK isoforms plus some of the other
inward-rectifying K1 channel polypeptides with or without
associated proteins such as CFTR are important questions
for future investigations.
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APPENDIX
Abbreviations used in this article are: ABC, ATP-binding cassette; ATP,
adenosine 59-triphosphate; CCD, cortical collecting duct; CFTR, cystic
fibrosis transmembrane regulator; CNT, connecting tubules; cTAL, corti-
cal thick ascending limb; DAB, 3,39-diaminobenzidine; ECL, enhanced
chemiluminescence; GST, glutathione S-transferase; HRP, horseradish
peroxidase; ICD, initial collecting duct; mTAL, medullary thick ascending
limb; OMCD, outer medulla collecting duct; PCR, polymerase chain
reaction; Po, open probability; ROMK, rat outer medulla K
1 channel;
ROMK-C, C-terminal domain of ROMK1; ROMK-N, N-terminus of
ROMK1; SK, secretory K1; TAL, thick ascending limb; TEA, tetraethyl-
ammonium; THP, Tamm-Horsfall protein.
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